Background and Objectives: The 1990s have established the contribution of multimodality therapy in the management of IIIb noninflammatory breast cancer (IIIb NIBC), by reducing the odds of recurrence and death. Methods: A total of 300 women with IIIb NIBC received a multimodality therapy. The treatm
β¦ LIBER β¦
Antihormone treatment of stage IV breast cancer
β Scribed by Andrea Manni; Jaime E. Trujillo; James S. Marshall; Jerald Brodkey; Olof H. Pearson
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 542 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Multimodality treatment of noninflammato
β
GliΕski, Bogdan; Pawlicki, Marek; Reinfuss, Marian; Skolyszewski, Jan; Brandys,
π
Article
π
1997
π
John Wiley and Sons
π
English
β 69 KB
π 2 views
Staging and treatment of clinically occu
β
Gordon F. Schwartz; Stephen A. Feig; Anne L. Rosenberg; Arthur S. Patchefsky; Am
π
Article
π
1984
π
John Wiley and Sons
π
English
β 580 KB
Prognostic indicators in stage III and l
β
D. Venkata Rao; John Bedwinek; Carlos Perez; Jeannette Lee; Barbara Fineberg
π
Article
π
1982
π
John Wiley and Sons
π
English
β 513 KB
Treatment of early-stage breast cancer i
β
Harris, Eleanor E.R.; Solin, Lawrence J.
π
Article
π
2000
π
John Wiley and Sons
π
English
β 58 KB
π 2 views
Mitoxantrone, methotrexate, and 5-fluoro
β
Werner R. Bezwoda; Charles S. Hesdorffer
π
Article
π
1986
π
John Wiley and Sons
π
English
β 353 KB
Fatigue after treatment for early stage
β
Paul B. Jacobsen; Kristine A. Donovan; Brent J. Small; Heather S. Jim; Pamela N.
π
Article
π
2007
π
John Wiley and Sons
π
English
β 105 KB
π 2 views
## Abstract ## BACKGROUND. Evidence suggests that fatigue may be a greater problem for cancer survivors than people without cancer. The present study sought to determine whether fatigue was greater in women who had completed treatment for earlyβstage breast cancer relative to a demographically mat